NIH to present the latest AIDS research advances at AIDS 2012
July 9, 2012 - The latest research illuminating progress and challenges in AIDS prevention and
treatment and the search for a cure for HIV infection will be presented by investigators supported by the U.S. National
Institutes of Health at the XIX International AIDS Conference (AIDS 2012).
Francis S. Collins, M.D., Ph.D., director, National Institutes of Health
Anthony S. Fauci, M.D., director, National Institute of Allergy and Infectious Diseases (NIAID)
Nora Volkow, M.D., director, National Institute on Drug Abuse (NIDA)
NIH intramural and extramural investigators
AIDS 2012, the largest gathering of HIV scientists, clinicians, policy-makers, service providers, and advocates in the world,
convened by the International AIDS Society (IAS). NIH, the world's leading funder of HIV/AIDS research, is the local
scientific partner for AIDS 2012.
Among the topics to be addressed by NIH-supported scientists at AIDS 2012 are:
- Advances in prevention, including the latest research on HIV vaccines, microbicides, medical male circumcision, pre-exposure prophylaxis (PrEP), prevention of mother-to-child transmission, and behavioral interventions; and research on improving HIV prevention outcomes in older people, infants, adolescents, women and girls, men who have sex with men (MSM), and substance users
- Research to improve HIV treatment outcomes in adults, adolescents, and pediatric populations; manage HIV drug resistance; and understand the potential impact of treatment as prevention
- Progress in understanding and managing the occurrence of HIV-associated co-morbidities and co-infections, including hepatitis C, tuberculosis, malignancies, and cardiovascular disease
- Research on efforts to improve HIV diagnosis, linkage to and retention in care, and adherence with treatment regimens
- Basic and therapeutic research to advance the understanding of viral reservoirs and their potential eradication; and possible research approaches toward a cure.
NIH Leadership Presentations
NIH leaders will be featured in several high-level sessions, including an opening day plenary address by Dr. Fauci entitled,
Ending the HIV Epidemic: From Scientific Advances to Public Health Implementation (Monday, July 23, 8:30 am; session
room 1). Dr. Fauci will highlight the growing armamentarium of scientifically proven interventions that offers an
unprecedented opportunity to make major gains in the fight against HIV/AIDS and bring an AIDS-free generation within reach.
NIH Director Dr. Francis Collins will speak at and moderate a session on The Future of Genomics in HIV Medicine (Wednesday,
July 27, 11:00 am; session room 1). Dr. Collins will also moderate a panel entitled, The Science of HIV: What Lies Ahead
(Monday, July 23, 1:00 pm; session room 5).
NIH Pre-Conference Satellite
In a satellite entitled New Frontiers in NIH AIDS Research, (Sunday, July 22, 11:15 a.m.; session room 6) NIH leaders including
Drs. Collins and Fauci, NIDA Director Dr. Nora Volkow, and others will present an overview of NIH research efforts to develop
improved therapies for HIV and its co-infections, malignancies, and complications; improve biomedical and behavioral
prevention tools; understand factors that affect HIV vulnerability and disease progression, including issues of
AIDS and aging; and eradicate HIV viral reservoirs.
At a pre-conference event, NIH scientists and grantees who have been involved in the IAS initiative, Towards an HIV Cure, will
participate in the release of a global scientific strategy for cure research on Thursday, July 19.
D.C. Partnership for HIV/AIDS Progress
One focus of NIH research to be presented at AIDS 2012 is the D.C. Partnership for HIV/AIDS Progress. A collaboration between NIH
and the D.C. Department of Health, the Partnership is designed to decrease the rate of new HIV infections in the city, improve
the health of district residents with HIV infection, and strengthen the city's response to the epidemic. The partnership
tracks HIV-associated health issues and outcomes across to city; provides risk-reduction counseling, condoms and
testing in communities at elevated risk; strengthens care for HIV co-infections, such as cardiovascular
disease, diabetes, and hepatitis; and is piloting a Test, Link-to-Care Plus Treat approach to expand
testing, link patients to care, promote adherence to therapy, and reduce community HIV levels.
|Where: Walter E. Washington Convention Center
|When: Sunday, July 22 - Friday, July 27, 2012
The NIH AIDS 2012 press kit, which includes a variety of fact sheets and other resources related to AIDS research at NIH, will be
available from July 10 at: http://aids2012.oar.nih.gov .
The Office of AIDS Research, a part of the Office of the NIH Director, coordinates the scientific, budgetary, legislative, and policy
elements of the NIH AIDS research program. OAR sets scientific priorities, enhances collaboration, and ensures that research dollars
are invested in the highest priority areas of scientific opportunity that will lead to new tools in the global fight against AIDS.
About the National Institutes of Health (NIH):
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and
Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research,
and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov .
NIH/National Institute of Child Health and Human Development
Source: NIH News
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS: